No-Vascath Policy

Authors

  • Sunai Janchai, M.D.

Keywords:

sucralose, sugar, artificial sweetener

Abstract

-

References

1. Rosas SE, Feldman HI. Synthetic vascular hemodialysis access versus native arteriovenous fistula:a cost-utility analysis. Ann Surg 2012;255(1):181-6.
2. Huber TS, Carter JW, Carter RL, et al. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses:a systematic review. J Vasc Surg 2003;38:1005-11.
3. National Kidney Foundation K/ DOQI Clinical practice guidelines for vascular access,2006 Updates. Am J Kidney Dis 2001;37:pp S137-S81.

Downloads

Published

2018-05-20

How to Cite

1.
Janchai S. No-Vascath Policy. Reg 4-5 Med J [internet]. 2018 May 20 [cited 2026 Jan. 1];34(2):99. available from: https://he02.tci-thaijo.org/index.php/reg45/article/view/124613

Issue

Section

Original Article